These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18814326)

  • 1. Phosphoproteomics, oncogenic signaling and cancer research.
    Chong PK; Lee H; Kong JW; Loh MC; Wong CH; Lim YP
    Proteomics; 2008 Nov; 8(21):4370-82. PubMed ID: 18814326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network.
    Morandell S; Stasyk T; Skvortsov S; Ascher S; Huber LA
    Proteomics; 2008 Nov; 8(21):4383-401. PubMed ID: 18846509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards functional phosphoproteomics by mapping differential phosphorylation events in signaling networks.
    de la Fuente van Bentem S; Mentzen WI; de la Fuente A; Hirt H
    Proteomics; 2008 Nov; 8(21):4453-65. PubMed ID: 18972525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plant phosphoproteomics: an update.
    Kersten B; Agrawal GK; Durek P; Neigenfind J; Schulze W; Walther D; Rakwal R
    Proteomics; 2009 Feb; 9(4):964-88. PubMed ID: 19212952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining the tumor phosphoproteome for cancer markers.
    Lim YP
    Clin Cancer Res; 2005 May; 11(9):3163-9. PubMed ID: 15867208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics and phosphoproteomics for the mapping of cellular signalling networks.
    Preisinger C; von Kriegsheim A; Matallanas D; Kolch W
    Proteomics; 2008 Nov; 8(21):4402-15. PubMed ID: 18846508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plant phosphoproteomics: a long road ahead.
    Kersten B; Agrawal GK; Iwahashi H; Rakwal R
    Proteomics; 2006 Oct; 6(20):5517-28. PubMed ID: 16991200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current challenges in quantitative modeling of epidermal growth factor signaling.
    Breitling R; Hoeller D
    FEBS Lett; 2005 Nov; 579(28):6289-94. PubMed ID: 16288752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of cell signaling and drug action via mass spectrometry-based systems level phosphoproteomics.
    Tedford NC; Hall AB; Graham JR; Murphy CE; Gordon NF; Radding JA
    Proteomics; 2009 Mar; 9(6):1469-87. PubMed ID: 19294625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoproteomics toolbox: computational biology, protein chemistry and mass spectrometry.
    Hjerrild M; Gammeltoft S
    FEBS Lett; 2006 Sep; 580(20):4764-70. PubMed ID: 16914146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative phosphoproteomics--an emerging key technology in signal-transduction research.
    Schreiber TB; Mäusbacher N; Breitkopf SB; Grundner-Culemann K; Daub H
    Proteomics; 2008 Nov; 8(21):4416-32. PubMed ID: 18837465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoproteomics strategies for the functional analysis of signal transduction.
    Morandell S; Stasyk T; Grosstessner-Hain K; Roitinger E; Mechtler K; Bonn GK; Huber LA
    Proteomics; 2006 Jul; 6(14):4047-56. PubMed ID: 16791829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mislocalized activation of oncogenic RTKs switches downstream signaling outcomes.
    Choudhary C; Olsen JV; Brandts C; Cox J; Reddy PN; Böhmer FD; Gerke V; Schmidt-Arras DE; Berdel WE; Müller-Tidow C; Mann M; Serve H
    Mol Cell; 2009 Oct; 36(2):326-39. PubMed ID: 19854140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. System properties of ErbB receptor signaling for the understanding of cancer progression.
    Hatakeyama M
    Mol Biosyst; 2007 Feb; 3(2):111-6. PubMed ID: 17245490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular cancer biology--from research to clinical practice].
    Nielsen FC
    Ugeskr Laeger; 2003 Feb; 165(9):897-900. PubMed ID: 12661511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phosphoproteomics and its application in cancer research].
    Liu JQ; He ZM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):559-64. PubMed ID: 18667765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional proteomics to identify critical proteins in signal transduction pathways.
    Yan GR; He QY
    Amino Acids; 2008 Aug; 35(2):267-74. PubMed ID: 17704892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of growth factor receptors with oncogenic potential.
    Chen E; Coussens L; Liao YC; Smith D; Yang-Feng TL; McGrath J; Van Beveren C; Verma IM; Libermann TA; Schlessinger J
    Biochem Soc Symp; 1986; 52():65-82. PubMed ID: 3579970
    [No Abstract]   [Full Text] [Related]  

  • 19. Receptor tyrosine kinase signaling: a view from quantitative proteomics.
    Dengjel J; Kratchmarova I; Blagoev B
    Mol Biosyst; 2009 Oct; 5(10):1112-21. PubMed ID: 19756300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Illuminating signaling network functional biology through quantitative phosphoproteomic mass spectrometry.
    Tedford NC; White FM; Radding JA
    Brief Funct Genomic Proteomic; 2008 Sep; 7(5):383-94. PubMed ID: 18836207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.